ARTICLE | Company News
Cytokine, Idec deal
September 15, 1997 7:00 AM UTC
IDPH exclusively licensed therapeutic and diagnostic applications of Cytokine Networks' anti-macrophage inhibitory factor ( MIF) antibody technology. IDPH will make a $3 million preferred equity inves...